Christophe Arbet-Engels, Chief Medical Officer: X4 Pharmaceuticals XFOR Sell · Filed 25/01/27

Trade details

Type: Insider sale
Amount: $5,230.8
Shares · price: 11,624 sh · $0.45 a share
Held after: 14,207 sh
Stock: X4 Pharmaceuticals XFOR
Person: Christophe Arbet-EngelsChief Medical Officer
Trade date: 25/01/24
Filed: 25/01/27
Days to filing: 3 days

Sold 45.0% of holdings

Share of holding sold: 45.0%

X4 Pharmaceuticals trades, last 26 weeks

What else happened in X4 Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/25~25/02/23

Christophe Arbet-Engels's recent trades

Christophe Arbet-EngelsOfficer
Planned sale10b5-1 planX4 Pharmaceuticals
Planned sale10b5-1 plan
X4 Pharmaceuticals
XFOR
$6,044
11,624 sh
$6,044
Filed 25/01/24
Traded 25/01/24